Xponance’s Hims & Hers Health HIMS Stock Holding History

Xponance’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	31,419 +2,014	+7%	+$54.1K	0.01%	765
2026 Q1	$610K	Buy	29,405 +4,258	+17%	+$101K	﹤0.01%	930
2025 Q4	$817K	Sell	25,147 -3,048	-11%	-$131K	0.01%	747
2025 Q3	$1.6M	Buy	28,195 +419	+2%	+$21.5K	0.01%	595
2025 Q2	$1.38M	Sell	27,776 -184	-0.7%	-$8.32K	0.01%	619
2025 Q1	$826K	Buy	27,960 +13,857	+98%	+$515K	0.01%	765
2024 Q4	$341K	Buy	14,103 +1,540	+12%	+$38.2K	﹤0.01%	1088
2024 Q3	$231K	Buy	12,563 +585	+5%	+$10.5K	﹤0.01%	1181
2024 Q2	$242K	Buy	+11,978	New	+$199K	﹤0.01%	1124

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Xponance's HIMS Position: Q2 2026 in Review

Xponance increased its Hims & Hers Health (HIMS) stake by 6.8% in Q2 2026, buying an estimated $54.1K and bringing the position to 31,419 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #765.

Xponance first reported a position in HIMS in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.6M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Xponance held 31,419 shares of Hims & Hers Health worth $1.09M as of Q2 2026.
Xponance bought 2,014 Hims & Hers Health shares in Q2 2026, an estimated $54.1K.
Hims & Hers Health made up 0.01% of Xponance's portfolio in Q2 2026, its #765 holding.
Xponance first reported a position in Hims & Hers Health in Q2 2024 and has held it in 9 quarters since.
Xponance's Hims & Hers Health position peaked at $1.6M in Q3 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.